DSE : PHARMAID

Pharma Aids Limited — Key statistics

Pharmaceutical Preparations · Bangladesh

Last price 544.6 BDT (At close: Oct 29, 2026) · Market cap 1.70B

Latest research: Pharma Aids financial analysis: 9M FY2026 sales up 17.6%, sponsors at 19.38% (Oct 2026) · Pharma Aids: FY2025 net sales of BDT 438m, 9M FY2026 sales up 17.6% and profit up 28.1%, sponsors at 19.38%

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap1.70B
Enterprise Value1.68B

Dates

MeasureValue
Earnings DateNov 4, 2026
Ex-Dividend DateDec 8, 2025

Shares

MeasureValue
Current Share Class3.12M
Shares Outstanding3.12M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)18.78%
Owned by Institutions (%)n/a
Float2.53M

Ratios

MeasureValue
PE Ratio21.88
Forward PEn/a
PS Ratio3.43
PB Ratio3.50
P/TBV Ratio3.50
P/FCF Ratio252.21
P/OCF Ratio27.01
PEG Ration/a

Evratios

MeasureValue
EV / Earnings21.60
EV / Sales3.38
EV / EBITDA14.77
EV / EBIT16.11
EV / FCF248.96

Financialposition

MeasureValue
Current Ratio3.20
Quick Ratio1.47
Debt / Equity0.04
Debt / EBITDA0.15
Debt / FCF2.56
Interest Coverage42.65

Financialefficiency

MeasureValue
Return on Equity (ROE)17.19%
Return on Assets (ROA)10.57%
Return on Invested Capital (ROIC)17.52%
Return on Capital Employed (ROCE)21.30%
Weighted Average Cost of Capital (WACC)5.30%
Revenue Per Employee5.27M
Profits Per Employee826,020
Employee Count94
Asset Turnover0.81
Inventory Turnover4.73

Taxes

MeasureValue
Income Tax24.12M
Effective Tax Rate23.70%

Stockprice

MeasureValue
Beta (5Y)0.18
52-Week Price Change+6.60%
50-Day Moving Average561.62
200-Day Moving Average561.14
Relative Strength Index (RSI)44.22
Average Volume (20 Days)9,455

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue495.70M
Gross Profit155.67M
Operating Income104.09M
Pretax Income101.77M
Net Income77.65M
EBITDA113.59M
EBIT104.09M
Earnings Per Share (EPS)24.89

Balancesheet

MeasureValue
Cash & Cash Equivalents39.16M
Total Debt17.26M
Net Cash21.89M
Net Cash Per Share7.02
Equity (Book Value)485.33M
Book Value Per Share155.55
Working Capital348.46M

Cashflow

MeasureValue
Operating Cash Flow62.91M
Capital Expenditures-56.17M
Depreciation & Amortization9.51M
Net Borrowing-325,993
Free Cash Flow6.74M
FCF Per Share2.16

Margins

MeasureValue
Gross Margin31.40%
Operating Margin21.00%
Pretax Margin20.53%
Profit Margin15.66%
EBITDA Margin22.92%
EBIT Margin21.00%
FCF Margin1.36%

Dividends

MeasureValue
Dividend Per Share3.00
Dividend Yield0.55%
Dividend Growth (YoY)20.00%
Years of Dividend Growth2
Payout Ratio12.49%
FCF Payout Ratio138.94%
Buyback Yieldn/a
Shareholder Yield0.55%
Earnings Yield4.57%
FCF Yield0.40%

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split DateDec 4, 2011
Split TypeForward
Split Ratio10

Scores

MeasureValue
Altman Z-Score9.17
Piotroski F-Score6

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside